URI-sponsored BEACON study seeks blood vessel inflammation, Alzheimer’s link

THE GEORGE & ANNE Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study. Above, Paula Grammas, executive director of the Ryan Institute. / COURTESY NORA LEWIS
THE GEORGE & ANNE Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study. Above, Paula Grammas, executive director of the Ryan Institute. / COURTESY NORA LEWIS
SOUTH KINGSTOWN — George & Anne Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study, the first such clinical trial led and conducted entirely within the state. The Phase 1 clinical trial, mainly funded by…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display